Deterministic Somatic Cell Reprogramming Involves Continuous Transcriptional Changes Governed by Myc and Epigenetic-Driven Modules.


Journal

Cell stem cell
ISSN: 1875-9777
Titre abrégé: Cell Stem Cell
Pays: United States
ID NLM: 101311472

Informations de publication

Date de publication:
07 02 2019
Historique:
received: 21 02 2018
revised: 21 09 2018
accepted: 09 11 2018
pubmed: 18 12 2018
medline: 28 3 2020
entrez: 18 12 2018
Statut: ppublish

Résumé

The epigenetic dynamics of induced pluripotent stem cell (iPSC) reprogramming in correctly reprogrammed cells at high resolution and throughout the entire process remain largely undefined. Here, we characterize conversion of mouse fibroblasts into iPSCs using Gatad2a-Mbd3/NuRD-depleted and highly efficient reprogramming systems. Unbiased high-resolution profiling of dynamic changes in levels of gene expression, chromatin engagement, DNA accessibility, and DNA methylation were obtained. We identified two distinct and synergistic transcriptional modules that dominate successful reprogramming, which are associated with cell identity and biosynthetic genes. The pluripotency module is governed by dynamic alterations in epigenetic modifications to promoters and binding by Oct4, Sox2, and Klf4, but not Myc. Early DNA demethylation at certain enhancers prospectively marks cells fated to reprogram. Myc activity drives expression of the essential biosynthetic module and is associated with optimized changes in tRNA codon usage. Our functional validations highlight interweaved epigenetic- and Myc-governed essential reconfigurations that rapidly commission and propel deterministic reprogramming toward naive pluripotency.

Identifiants

pubmed: 30554962
pii: S1934-5909(18)30550-2
doi: 10.1016/j.stem.2018.11.014
pmc: PMC7116520
mid: EMS108840
pii:
doi:

Substances chimiques

Chromatin 0
KLF4 protein, human 0
Klf4 protein, mouse 0
Kruppel-Like Factor 4 0
Proto-Oncogene Proteins c-myc 0
Transcription Factors 0
RNA, Transfer 9014-25-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

328-341.e9

Subventions

Organisme : European Research Council
ID : 726497
Pays : International

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Références

Nature. 2014 Dec 11;516(7530):198-206
pubmed: 25503233
Cell. 2006 Aug 25;126(4):663-76
pubmed: 16904174
Cell Stem Cell. 2018 Sep 6;23(3):412-425.e10
pubmed: 30122475
Nature. 2014 Feb 13;506(7487):235-9
pubmed: 24336202
Nat Biotechnol. 2008 Jan;26(1):101-6
pubmed: 18059259
Cell. 2014 Sep 11;158(6):1281-1292
pubmed: 25215487
Cell. 2015 Sep 24;163(1):218-29
pubmed: 26406378
Cell Stem Cell. 2017 Dec 7;21(6):819-833.e6
pubmed: 29220666
Nature. 2014 Oct 16;514(7522):376-9
pubmed: 25186725
Nat Commun. 2014 Dec 10;5:5619
pubmed: 25493341
Nat Methods. 2010 Jan;7(1):56-9
pubmed: 20010831
Cell. 2015 Apr 23;161(3):555-568
pubmed: 25892221
Cell. 2012 Dec 21;151(7):1617-32
pubmed: 23260147
Nature. 2013 Oct 3;502(7469):65-70
pubmed: 24048479
Cell. 2010 Apr 30;141(3):432-45
pubmed: 20434984
Cell. 2016 Feb 11;164(4):668-80
pubmed: 26871632
Cell. 2017 Jan 26;168(3):442-459.e20
pubmed: 28111071

Auteurs

Asaf Zviran (A)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 761001, Israel; New York Genome Center, New York, NY, USA.

Nofar Mor (N)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 761001, Israel.

Yoach Rais (Y)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 761001, Israel. Electronic address: yoach.rais@weizmann.ac.il.

Hila Gingold (H)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 761001, Israel.

Shani Peles (S)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 761001, Israel.

Elad Chomsky (E)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 761001, Israel; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel; Department of Computer Science, Weizmann Institute of Science, Rehovot, Israel.

Sergey Viukov (S)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 761001, Israel.

Jason D Buenrostro (JD)

Broad Institute of MIT and Harvard, Cambridge, MA, USA; Harvard Society of Fellows, Harvard University, Cambridge, MA, USA.

Roberta Scognamiglio (R)

Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Leehee Weinberger (L)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 761001, Israel.

Yair S Manor (YS)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 761001, Israel.

Vladislav Krupalnik (V)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 761001, Israel.

Mirie Zerbib (M)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 761001, Israel.

Hadas Hezroni (H)

Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.

Diego Adhemar Jaitin (DA)

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.

David Larastiaso (D)

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.

Shlomit Gilad (S)

Israel National Center for Personalized Medicine (G-INCPM), Weizmann Institute of Science, Rehovot, Israel.

Sima Benjamin (S)

Israel National Center for Personalized Medicine (G-INCPM), Weizmann Institute of Science, Rehovot, Israel.

Ohad Gafni (O)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 761001, Israel.

Awni Mousa (A)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 761001, Israel.

Muneef Ayyash (M)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 761001, Israel.

Daoud Sheban (D)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 761001, Israel; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.

Jonathan Bayerl (J)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 761001, Israel.

Alejandro Aguilera-Castrejon (A)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 761001, Israel.

Rada Massarwa (R)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 761001, Israel.

Itay Maza (I)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 761001, Israel; Department of Gastroenterology, Rambam Hospital, Haifa, Israel.

Suhair Hanna (S)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 761001, Israel; Department of Pediatrics, Rambam Hospital, Haifa, Israel.

Yonatan Stelzer (Y)

Department of Molecular and Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Igor Ulitsky (I)

Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.

William J Greenleaf (WJ)

Department of Genetics, Stanford University, Palo Alto, CA, USA; Chan Zuckerberg Biohub, San Francisco, CA, USA.

Amos Tanay (A)

Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel; Department of Computer Science, Weizmann Institute of Science, Rehovot, Israel.

Andreas Trumpp (A)

Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Ido Amit (I)

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.

Yitzhak Pilpel (Y)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 761001, Israel.

Noa Novershtern (N)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 761001, Israel. Electronic address: noa.novershtern@weizmann.ac.il.

Jacob H Hanna (JH)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 761001, Israel. Electronic address: jacob.hanna@weizmann.ac.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH